Driven by the increasing demand for diagnostic imaging, Australia’s computed tomography (CT) systems market is benefiting from the need for improved image quality, efficient workflows, and broader clinical applications. Continued investment in CT equipment and diagnostic services is also supporting the market development. As a result, Australia’s CT systems market is expected to grow at a 3% CAGR between 2025-2033, forecasts GlobalData, a leading intelligence and productivity platform. 

GlobalData’s report, “Australia Computed Tomography (CT) Systems Market Outlook to 2033: 256-320 slice CT Systems, 128-slice CT Systems, 64-slice CT Systems and Others,” reveals that Australia’s CT systems market is being supported by continued use of CT imaging across diagnostic services and the introduction of systems with enhanced imaging capabilities. Providers are evaluating CT equipment based on clinical requirements, image quality, and operational efficiency. 

In this context, Koning Health’s Koning Breast CT System “CBCT 1000” has received regulatory approval in Australia and has been included in the Australian Register of Therapeutic Goods (ARTG). The system uses cone-beam CT to generate three-dimensional images of the breast without compression, adding a specialized breast-imaging option to the Australian market.

Anindita Ghosh, Medical Devices Analyst at GlobalData, comments: “Australia is witnessing continued development across the CT landscape, with healthcare providers adopting technologies that address evolving clinical and operational requirements. The regulatory approval of Koning Health’s Breast CT System highlights the continued expansion of specialised imaging applications in the country.

The development could create additional opportunities for manufacturers targeting specialized imaging applications. Broader commercial uptake will depend on how seamlessly the system fits into the established clinical workflows, as well as its ability to prove clear clinical and economic value alongside mainstream breast-imaging tools such as mammography, ultrasound, and MRI.”

Its impact on the wider CT market will also depend on market scope, as dedicated breast systems serve a different clinical need than the whole-body scanners standard in diagnostic radiology.

Ghosh concludes: “The Australian CT systems market is anticipated to grow steadily due to the upgradation of existing systems and analysis of new technologies in the healthcare environment. The introduction of specialized systems could further diversify the market. However, commercial uptake will depend on how healthcare providers assess the clinical benefits, cost-effectiveness, and compatibility of these technologies with existing imaging practices.”